These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31424573)

  • 1. Prevention of ventricular fibrillation through de-networking of the Purkinje system: Proof-of-Concept Paper on the Substrate Modification of the Purkinje Network.
    Imnadze G; Zerm T
    Pacing Clin Electrophysiol; 2019 Oct; 42(10):1285-1290. PubMed ID: 31424573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catheter ablation in patients with ventricular fibrillation by purkinje de-networking.
    Sciacca V; Fink T; Guckel D; El Hamriti M; Khalaph M; Braun M; Sohns C; Sommer P; Imnadze G
    Front Cardiovasc Med; 2022; 9():956627. PubMed ID: 36247422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fascicular Substrate Modification to Treat Human Ventricular Fibrillation.
    Bode WD; Mohanty S; Burkhardt JD; Torlapati PG; Gianni C; La Fazia VM; Della Rocca DG; Bassiouny M; Gallinghouse GJ; Horton R; Al-Ahmad A; Zhang XD; Zou F; Di Biase L; Santangeli P; Natale A
    JACC Clin Electrophysiol; 2024 Aug; 10(8):1781-1790. PubMed ID: 38878012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of left ventricular scar and Purkinje-like potentials during mapping and ablation of ventricular fibrillation in dilated cardiomyopathy.
    Sinha AM; Schmidt M; Marschang H; Gutleben K; Ritscher G; Brachmann J; Marrouche NF
    Pacing Clin Electrophysiol; 2009 Mar; 32(3):286-90. PubMed ID: 19272055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion to Purkinje-Related Monomorphic Ventricular Tachycardia After Ablation of Ventricular Fibrillation in Ischemic Heart Disease.
    Masuda K; Nogami A; Kuroki K; Igarashi M; Sekiguchi Y; Komatsu Y; Kowase S; Kurosaki K; Nishihara S; Niwa K; Tsuchiya T; Igawa M; Aonuma K
    Circ Arrhythm Electrophysiol; 2016 Sep; 9(9):. PubMed ID: 27635070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purkinje-related arrhythmias part ii: polymorphic ventricular tachycardia and ventricular fibrillation.
    Nogami A
    Pacing Clin Electrophysiol; 2011 Aug; 34(8):1034-49. PubMed ID: 21671950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purkinje network and myocardial substrate at the onset of human ventricular fibrillation: implications for catheter ablation.
    Haissaguerre M; Cheniti G; Hocini M; Sacher F; Ramirez FD; Cochet H; Bear L; Tixier R; Duchateau J; Walton R; Surget E; Kamakura T; Marchand H; Derval N; Bordachar P; Ploux S; Takagi T; Pambrun T; Jais P; Labrousse L; Strik M; Ashikaga H; Calkins H; Vigmond E; Nademanee K; Bernus O; Dubois R
    Eur Heart J; 2022 Mar; 43(12):1234-1247. PubMed ID: 35134898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping and ablating ventricular premature contractions that trigger ventricular fibrillation: trigger elimination and substrate modification.
    Nogami A
    J Cardiovasc Electrophysiol; 2015 Jan; 26(1):110-5. PubMed ID: 25216244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of ventricular fibrillation by electrical modification of the Purkinje system in hypertrophic cardiomyopathy.
    Yokoshiki H; Mitsuyama H; Watanabe M; Mizukami K; Tsutsui H
    Heart Vessels; 2014 Sep; 29(5):709-17. PubMed ID: 24113718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localized Structural Alterations Underlying a Subset of Unexplained Sudden Cardiac Death.
    Haïssaguerre M; Hocini M; Cheniti G; Duchateau J; Sacher F; Puyo S; Cochet H; Takigawa M; Denis A; Martin R; Derval N; Bordachar P; Ritter P; Ploux S; Pambrun T; Klotz N; Massoullié G; Pillois X; Dallet C; Schott JJ; Scouarnec S; Ackerman MJ; Tester D; Piot O; Pasquié JL; Leclerc C; Hermida JS; Gandjbakhch E; Maury P; Labrousse L; Coronel R; Jais P; Benoist D; Vigmond E; Potse M; Walton R; Nademanee K; Bernus O; Dubois R
    Circ Arrhythm Electrophysiol; 2018 Jul; 11(7):e006120. PubMed ID: 30002064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrical Substrate Elimination in 135 Consecutive Patients With Brugada Syndrome.
    Pappone C; Brugada J; Vicedomini G; Ciconte G; Manguso F; Saviano M; Vitale R; Cuko A; Giannelli L; Calovic Z; Conti M; Pozzi P; Natalizia A; Crisà S; Borrelli V; Brugada R; Sarquella-Brugada G; Guazzi M; Frigiola A; Menicanti L; Santinelli V
    Circ Arrhythm Electrophysiol; 2017 May; 10(5):e005053. PubMed ID: 28500178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping and ablation of ventricular fibrillation-how and for whom?
    Willems S; Hoffmann BA; Schaeffer B; Sultan A; Schreiber D; Lüker J; Steven D
    J Interv Card Electrophysiol; 2014 Sep; 40(3):229-35. PubMed ID: 24626997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping and Ablation of Ventricular Fibrillation Associated With Early Repolarization Syndrome.
    Nademanee K; Haissaguerre M; Hocini M; Nogami A; Cheniti G; Duchateau J; Behr ER; Saba M; Bokan R; Lou Q; Amnueypol M; Coronel R; Khongphatthanayothin A; Veerakul G
    Circulation; 2019 Oct; 140(18):1477-1490. PubMed ID: 31542949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiform premature ventricular contractions and polymorphic ventricular tachycardia caused by Purkinje activity with slow conduction in idiopathic ventricular fibrillation.
    Nagase S; Banba K; Nishii N; Morita H; Fukushima Kusano K; Ohe T; Ito H
    Intern Med; 2014; 53(7):725-8. PubMed ID: 24694485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mode of initiation and ablation of ventricular fibrillation storms in patients with ischemic cardiomyopathy.
    Marrouche NF; Verma A; Wazni O; Schweikert R; Martin DO; Saliba W; Kilicaslan F; Cummings J; Burkhardt JD; Bhargava M; Bash D; Brachmann J; Guenther J; Hao S; Beheiry S; Rossillo A; Raviele A; Themistoclakis S; Natale A
    J Am Coll Cardiol; 2004 May; 43(9):1715-20. PubMed ID: 15120835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purkinje triggers of ventricular fibrillation in patients with hypertrophic cardiomyopathy.
    Hocini M; Ramirez FD; Szumowski Ł; Maury P; Cheniti G; Duchateau J; Pambrun T; Derval N; Sacher F; Cochet H; Jaïs P; Haïssaguerre M
    J Cardiovasc Electrophysiol; 2021 Nov; 32(11):2987-2994. PubMed ID: 34453363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ablation of polymorphic ventricular tachycardias in patients with structural heart disease.
    Bode K; Hindricks G; Piorkowski C; Sommer P; Janousek J; Dagres N; Arya A
    Pacing Clin Electrophysiol; 2008 Dec; 31(12):1585-91. PubMed ID: 19067811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary prevention.
    Streitner F; Kuschyk J; Dietrich C; Mahl E; Streitner I; Doesch C; Veltmann C; Schimpf R; Wolpert C; Borggrefe M
    Clin Cardiol; 2011 Oct; 34(10):604-9. PubMed ID: 21887690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mechanism of postinfarction ventricular tachycardia originating in surviving left posterior Purkinje fibers.
    Hayashi M; Kobayashi Y; Iwasaki YK; Morita N; Miyauchi Y; Kato T; Takano T
    Heart Rhythm; 2006 Aug; 3(8):908-18. PubMed ID: 16876739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.